Bristol-Myers Squibb and California Institute for Biomedical Research Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases
January 05, 2015 at 08:01 AM EST
Bristol-Myers Squibb Company (NYSE: BMY) and the California Institute for Biomedical Research (Calibr) announced today they have entered ...